WHAT DOES
OXBRYTA DO?

MUYIWA

Father, bongo player, and actual Oxbryta patient

OXBRYTA IS A ONCE-DAILY, FDA-APPROVED TREATMENT

Oxbryta may reduce sickling and help red blood cells deliver oxygen throughout the body.

Hemoglobin and sickling process

Red Blood Cell

Oxbryta attaches to sickle hemoglobin to help keep it from clumping together.


Oxbryta may reduce sickling

Oxbryta may affect hemoglobin levels by impacting the first step in the process—polymerization.

Since 2019, more than 15,000 PATIENTS have
been prescribed Oxbryta*

* Based on US patient claims collected from initial approval in November 2019 up to August 2023.



SEE OXBRYTA IN ACTION

Oxbryta is a once-daily FDA-approved treatment that addresses sickle cell in a different way—by working directly on hemoglobin to interfere with the process that causes red blood cells to sickle.

"I’m in the band. I like playing my trumpet. I like hanging out with my friends and my family. So, I make sure I’m hydrated and rested."

– TULLY

Actual Oxbryta patient

TULLY

Actual Oxbryta patient